Zomedica Pharmaceuticals Corp Stock Analysis
| ZOM Stock | USD 0.05 0.01 41.13% |
Zomedica Pharmaceuticals Corp is undervalued with Real Value of 0.0995 and Hype Value of 0.05. The main objective of Zomedica Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Zomedica Pharmaceuticals Corp is worth, separate from its market price. There are two main types of Zomedica Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Zomedica Pharmaceuticals stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Zomedica Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Zomedica Stock trading window is adjusted to America/New York timezone.
Zomedica |
Zomedica Stock Analysis Notes
The company has Price to Book (P/B) ratio of 0.25. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zomedica Pharmaceuticals recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 47 people. For more information please call Robert Cohen at 734 369 2555 or visit https://www.zomedica.com.Zomedica Pharmaceuticals Investment Alerts
| Zomedica Pharmaceuticals generated a negative expected return over the last 90 days | |
| Zomedica Pharmaceuticals has high historical volatility and very poor performance | |
| Zomedica Pharmaceuticals has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 27.29 M. Reported Net Loss for the year was (46.98 M) with profit before taxes, overhead, and interest of 13.65 M. | |
| Zomedica Pharmaceuticals Corp has about 27.4 M in cash with (23.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Zomedica Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Zomedica Pharmaceuticals Upcoming and Recent Events
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Zomedica Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 147.6 M.Zomedica Profitablity
The company has Net Profit Margin of (2.15) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.47) %, which entails that for every $100 of revenue, it lost $1.47.Technical Drivers
As of the 17th of March 2025, Zomedica Pharmaceuticals maintains the Standard Deviation of 10.52, mean deviation of 5.0, and Market Risk Adjusted Performance of 0.5653. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zomedica Pharmaceuticals Corp, as well as the relationship between them. Please check out Zomedica Pharmaceuticals market risk adjusted performance and treynor ratio to decide if Zomedica Pharmaceuticals is priced fairly, providing market reflects its latest price of 0.0501 per share. As Zomedica Pharmaceuticals appears to be a penny stock we also urge to confirm its jensen alpha numbers.Zomedica Pharmaceuticals Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Zomedica Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Zomedica Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Zomedica Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zomedica Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zomedica Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zomedica Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zomedica Pharmaceuticals Outstanding Bonds
Zomedica Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zomedica Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zomedica bonds can be classified according to their maturity, which is the date when Zomedica Pharmaceuticals Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Zomedica Pharmaceuticals Predictive Daily Indicators
Zomedica Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zomedica Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.27 | |||
| Daily Balance Of Power | 1.042857 | |||
| Rate Of Daily Change | 1.41 | |||
| Day Median Price | 0.045 | |||
| Day Typical Price | 0.0467 | |||
| Market Facilitation Index | 0.014 | |||
| Price Action Indicator | 0.0124 | |||
| Period Momentum Indicator | 0.0146 |
Zomedica Pharmaceuticals Forecast Models
Zomedica Pharmaceuticals' time-series forecasting models are one of many Zomedica Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zomedica Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Zomedica Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Zomedica Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zomedica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Zomedica Pharmaceuticals. By using and applying Zomedica Stock analysis, traders can create a robust methodology for identifying Zomedica entry and exit points for their positions.
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 47 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zomedica Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.